Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ESLA
#3526
Estrella Immunopharma, Inc. Common Stock
1.2
2
+0.83%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
+0.83%
Monthly Change
+10.91%
6 month change
+29.79%
Year Change
+25.77%
Previous Close
1.2
1
Open
1.2
2
Bid
Ask
Low
1.2
2
High
1.2
2
Volume
1
Markets
US Stock Market
Healthcare
ESLA
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
2021
2022
2023
Total assets
45.8 M
9.72 M
4.45 M
Total liabilities
1.62 M
2.65 M
180.7 K
Total equity
-1.01 M
-2.26 M
4.27 M
Total liabilities & shareholders' equities
45.8 M
9.72 M
4.45 M
Total debt
—
—
—
Net debt
—
—
—
News
Estrella reports 100% complete response rate in lymphoma trial
Estrella to present phase 1 data on CD19-targeted cell therapy
Estrella Immunopharma receives Nasdaq notice for delayed annual meeting
Estrella Immunopharma closes $8 million registered direct offering
Estrella Immunopharma stock falls after announcing $8 million offering
Estrella Immunopharma raises $8 million through registered offering
Estrella Immunopharma stock rises as cancer therapy advances to Phase II
Estrella’s EB103 advances to Phase II after positive safety data
Estrella Immunopharma stock soars after 100% complete response rate in trial
Estrella’s lymphoma therapy shows 100% response rate in phase I trial
Estrella Immunopharma regains Nasdaq compliance after capital raise
Estrella Immunopharma regains Nasdaq compliance on bid price and market value